Drug – bio-affecting and body treating compositions – Solid synthetic organic polymer as designated organic active... – Polymer from ethylenic monomers only
Patent
1992-11-17
1993-10-05
Rollins, John W.
Drug, bio-affecting and body treating compositions
Solid synthetic organic polymer as designated organic active...
Polymer from ethylenic monomers only
A61K 31745
Patent
active
052502945
ABSTRACT:
In accordance with the present invention, a composition and method is provided for perfusion of organs. The present invention includes perfusion of organs in situ and before transplantation. The method comprises perfusing an organ with a perfusion medium containing an effective amount of a surface active copolymer. The surface active copolymer can be an ethylene oxide-propylene oxide condensation product with the following general formula:
REFERENCES:
patent: Re29909 (1979-02-01), Kurtz
patent: 2674619 (1954-04-01), Lundsted
patent: 2854378 (1958-09-01), Buckwalter et al.
patent: 3089818 (1963-05-01), Stone
patent: 3140232 (1964-07-01), Noseworthy
patent: 3450502 (1969-06-01), Hymes
patent: 3577522 (1971-05-01), Hymes
patent: 3590125 (1971-06-01), Hymes
patent: 3740421 (1973-06-01), Schmolka
patent: 3867521 (1975-02-01), Miskel et al.
patent: 3956259 (1976-05-01), Garcia et al.
patent: 3980772 (1976-09-01), Ginger et al.
patent: 4073886 (1978-02-01), Kehm
patent: 4100271 (1978-07-01), Kreszanoski
patent: 4186253 (1980-01-01), Yokoyama et al.
patent: 4395393 (1983-07-01), Schmolka
patent: 4407790 (1983-10-01), Oakes et al.
Schmolka, I., "A Review Of Block Polymer Surfactants", Journal of the American Oil Chemists Society, 54, No. 3, pp. 110-116 (1977).
Block and Graft Copolymerization, vol. 2, (ed. by R. J. Ceresa, John Wiley & Sons, 1976), "The Applications of Block Copolymer Polyol Surfactants", L G. Lundsted and I. R. Schmolka; pp. 174-205 and pp. 255-272 (references).
Kanter, K. R., et al. "Superiority of perfluorocarbon cardioplegia over blood or crystalloid cardioplegia", Circulation, vol. 64, pp. II-75-II-80 (1981).
Harjula, A., et al., "Perfluorocarbon solution as a myocardial preservative", J. Applied Cardiology, vol. 2, pp. 121-136 (1987).
Hoie, J., et al., "Effects of Pluronic.RTM. F68, Poloralkol, On Vascular Resistance In Vivo", Journal of Surgical Research, vol. 11, pp. 515-517 (1971).
Ketchum, L. D., et al., "Experimental Use Of Pluronic.RTM. F-68 In Microvascular Surgery", Plastic and Reconstructive Surgery, vol. 53, pp. 288-292 (1974).
Ketchum, L. D. "Experimental Use Of Pluronic F-68 In Microvascular Surgery", Plastic and Reconstructive Surgery, vol. 54, p. 478 (Oct. 1974).
Benner, K. U., et al., "Cold-Induced Platelet Aggregation In Vivo And Its Inhibition By A Nonionic Surface Active Substance", Thrombosis Research, vol. 2, pp. 331-332 (1973).
Benner, K. U., et al., "Uber die Wirkung von Pluronic.RTM. F68, einem Poloxypropylen-Polyoxyyyathylen-Kondensat, auf die ADP-induzierte Thrombocytenaggregation in vitro", Pfuger Arch., vol. 315, pp. 45-52 (1970).
Gaehtgens, P., et al., "Disaggregation of Human Red Blood Cells by Various Surface-Active Agents as Related to Changes of Cell Shape and Hemolysis", Act Heamat. vol. 33, pp. 82-89 (1975).
Grover, F. L., et al., "A Nonionic Surfactant And Blood Viscosity", Arch. Surg., vol. 106, pp. 307-310 (1973).
Vasko, K. A., et al., "Poloxalkol.RTM. (Pluronic F-68): A Priming Solution for Cardiopulmonary Bypass", Trans. Am. Soc. Artif. Int. Organs, 18, 526-531 (1972).
Organ Perfusion and Preservation, (ed. by Norman, J. C., Appleton-Century-Crofts, (1968)), Paton, B. C., et al. "The use of a nonionic detergent added to organ perfusates" pp. 105-120.
Grover, F. L. et al., "The Effect of Pluronic.RTM. F-68 On Circulatory Dynamics And Renal And Carotid Artery Flow During Hemorrhagic Shock", Journal of Surgical Research, vol. 17, pp. 30-35 (1974).
Hymes, A. C., et al., "The Influence Of An Industrial Surfactant Pluronic.RTM. F-68, In The Treatment of Hemorrhagic Shock", Journal of Surgical Research, vol. 11, pp. 191-197 (1971).
Advances in Blood Substitute Research (ed. by Bolin, et al., Alan R. Liss, Inc. New York, (1983)) Sugi, et al., The use of Fluosol-DA (FDA) in emergency situations: a report of 67 clinical cases, Abstract/451.
Vercellotti, G. M., et al., "Activation of Plasma Complement by Perfluorocarbon Artificial Blood: Probable Mechanism of Adverse Pulmonary Reactions in Treated Patients and Rationale for Corticosteroid Prophylaxis", Blood, vol. 59, pp. 1299-1304 (1982).
Forman, M. B., et al., "Reduction of infarct size with intracoronary perfluorochemical in a canine preparation of reperfusion", Circulation, vol. 71, 1060-1068 (1985).
Forman, M. B., et al., "Beneficial long-term effect of intracoronary perfluorochemical on infarct size and ventricular function in a canine reperfusion model", J. Am. Co. of Cardiol., pp. 1082-1090 (May, 1987).
Tokioka, M. D., et al., "Effects of intracoronary infusion of arterial blood or Fluosol-DA 20% on regional myocardial metabolism and function during brief coronary artery occlusions", Laboratory Investigation, vol. 75, pp. 474-481 (1987).
Lane, T. A., et al., "Paralysis of phagocyte migration due to an artificial blood substitute", Blood, vol. 64, pp. 400-405 (1984).
Heron, M. W., et al., "A Method for Measuring a Nonionic Surface-Active Agent (Pluronic F-68) in Biological Fluids," Analytical Biochemistry, vol. 24, pp. 491-495 (1968).
Uno, T., et al, "Determination of Surface-Active Agents, VIII. Infrared Determination of the Proporation of Ethylene Oxide and Propylene Oxide in Pluronic," Chem. Pharm. Bull., vol. 15(1), pp. 77-82 (1967).
Hymes, A. C., et al., "Influence of an industrial surfactant (Pluronic F-68) on human amniotic fluid embolism," American Journal Obstetrics and Gynecology, vol. 107(8), pp. 1217-1222 Aug. 15, 1970).
Grover, F. L., et al., "Beneficial Effect of Pluronic F-68 on the Microcirculation in Expiramental Hemorrhagic Shock," Surgical Forum, vol. 21, pp. 30-31 (1970).
Maugh, T. H., "Perfluorochemical Emulsions: Promising Blood Substitutes," Science, vol. 179, pp. 669-672 (Feb. 1973).
Justice, C., et al., "Prevention of Thrombosis with Agents which Reduce Platelets Adhesiveness," The American Surgeon, vol. 40, pp. 186-189 (Mar. 1974).
Danielson, G., et al, "Use of Pluronic F-68 to Dimish Fat Emboli and Hemolysis During Cardiopulmonary Bypass," The Journal of Thoracic and Cardiovascular Surgery, vol. 59(2), pp. 178-184 (Feb. 1970).
Reindorf, C. A., et al., "Perfluorocarbon Compounds: Effects on the Rheological Properties of Sickle Erythrocytes in vitro," American Journal of Hematology, vol. 19, pp. 229-236 (1985).
Padilla, F., et al., "Effect of Fluorocarbon emulsions on the mechanical fragility of normal and sickle cells: in vitro studies" Federation Proceedings, vol. 34, pp. 1510-1512 (1975).
Rodeheaver, G. T., "Pluronic.RTM. F-68: a Promising New Skin Wound Cleanser", Ann Emerg Med, 9:11, pp. 572-576 (1980).
Janoff, A. S., et al., "The Modification of Human Erythrocyte Membrane Structure by Membrane Stabilizers: An Electron Spin Resonance Study", American Journal of Hematology vol. 10, pp. 171-179 (1981).
Moore, A. R. et al, "Reduction of Splenic Vascular Resistance During Profusion By Pluronic.RTM. F-68", Journal of Surgical Research, vol. 8, pp. 563-566 (1968).
Ketchum, L. D., "Pharmacological alterations in the clotting mechanism: Use in microvascular surgery", Journal of Hand Surgery, vol. 3, pp. 407-415 (1978).
Block, N. L., et al., "Acutely Traumatized Canine Ureter: Effects of Low Molecular Weight Dextran and Surfactant Pluronic F-68", Urology, vol. III 190-194 (1974).
Knize, D. M., et al., "Use of Antisludging Agents in Experimental Cold Injuries," Surgery, Gynecology & Obstetrics, vol. 129, pp. 1019-1026 (1969).
Smillie, J. A., et al., "Cryopreservation of Human Platelets with Polyvinylpyrrolidone", Transfusion, vol. 21, pp. 552-556 (1981).
Lane, T. A., et al., "Reduction in the toxicity of a component of an artificial blood substitute by supercritical fluid fractionation", Transfusion, vol. 28, pp. 375-378 (1987).
Spiess, B. D., et al., "Protection from Cerebral Air Emboli with Perfluorocarbons in Rabbits", Stroke, vol. 17, pp. 1146-1149 (1986).
Goodman, R. L. et al., "Perfluorocarbon Emulsions in Cancer Therapy: Preliminary Observations on Presently Available Formulations", Int. J. Radiation Oncology Biol. Phys., vol. 10, pp. 1421-1424 (1984).
Technical bulletin entitled "Performance Chemicals".
Technical bulletin entitled "Pluronic.RTM. Bloc
Duncan Alexander
Hunter Robert L.
Emory University
Rollins John W.
LandOfFree
Improved perfusion medium for transplantation of organs does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Improved perfusion medium for transplantation of organs, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Improved perfusion medium for transplantation of organs will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1002192